Non-Sexually Acquired Genital Ulceration
Understanding painful genital ulcers unrelated to sexual activity: causes, diagnosis, and management in adolescents and young women.
Non-sexually acquired genital ulceration (NSAGU), also known as acute genital ulcer or Lipschütz ulcer, refers to the sudden onset of one or more painful vulval ulcers in adolescent girls who are not sexually active. These lesions are typically self-limiting, healing without scarring in 2–6 weeks with symptomatic management. NSAGU is a diagnosis of exclusion after ruling out infectious, autoimmune, and traumatic causes.
What is the cause of non-sexually acquired genital ulceration?
The aetiology of NSAGU remains largely unknown, with up to 70% of cases classified as idiopathic. Proposed triggers include preceding viral infections such as Epstein–Barr virus (EBV), cytomegalovirus (CMV), adenovirus, parvovirus B19, influenza, mycoplasma, and rarely HIV or paratyphoid fever. These infections may provoke an acute hypersensitivity reaction or immune dysregulation targeting vulval mucosa, particularly in hormonally active adolescents.
Non-infectious associations include emotional stress, trauma, and hormonal fluctuations in early puberty, though evidence is anecdotal. Histopathology shows non-specific features: lymphocytic vasculitis, fibrinoid necrosis, and dense lymphocytic infiltrate without viral inclusions, supporting a reactive rather than direct infectious process.
Who gets non-sexually acquired genital ulceration?
NSAGU predominantly affects females aged 10–25 years, with mean age around 14 years, corresponding to early puberty. Over 90% occur in virginal adolescents without sexual history. Rare cases reported in pre-pubertal girls, adult women, and exceptionally males. Systemic prodromal symptoms like fever, malaise, pharyngitis, or diarrhoea precede ulcers in 50–90% of cases.
- High-risk group: Adolescent females (12–18 years)
- Predisposing factors: Recent viral illness, immune reactivity
- Risk modifiers: Hormonal changes, genetic predisposition to aphthosis
What are the clinical features of non-sexually acquired genital ulceration?
Lesions appear acutely 1–3 days after prodrome, manifesting as single or multiple (1–12) deep, punched-out ulcers 0.5–4 cm on labia minora, vestibule, or perineum. Classic “kissing ulcers” oppose across midline. Morphology: yellow-grey fibrinous base, erythematous halo, oedema; may necrose forming gangrenous appearance.
Symptoms: Severe pain (dysuria, dyspareunia, urinary retention), inguinal lymphadenopathy (60%), fever (50%). Oral aphthae coexist in 20–70%. Progression: Ulcers deepen over 48–72 hours, then epithelialize without scarring in 2–6 weeks. Recurrent episodes in 10–20%, sometimes chronic.
| Feature | Description |
|---|---|
| Location | Labia minora (90%), vestibule, fourchette, perineum |
| Appearance | Deep ulcers, necrotic base, oedematous halo |
| Pain | Severe; limits walking, urination |
| Duration | 2–6 weeks; self-healing |
Diagnosis of non-sexually acquired genital ulceration
Clinical diagnosis requires exclusion of sexually transmitted infections (STI), inflammatory bowel disease, Behçet’s syndrome, and malignancy. History emphasizes non-sexual exposure, prodromal illness. Examination reveals characteristic symmetrical ulcers without discharge or induration.
Investigations
- Microbiology: Swabs for HSV PCR (negative), bacterial culture, syphilis serology
- Serology: EBV/CMV IgM, HIV, ANA if recurrent
- Biopsy: Reserved for atypical/recurrent cases; shows lymphocytic infiltrate
- Other: FBC, CRP, stool calprotectin (rule out Crohn’s), urinalysis
Differential includes HSV (vesicles, recurrence), chancroid (purulent), aphthous ulcers of Crohn’s/Behçet’s (systemic features), trauma.
How is non-sexually acquired genital ulceration treated?
Treatment is supportive as ulcers heal spontaneously. Focus on analgesia, hygiene, and secondary infection prevention.
- Pain relief: Topical lidocaine 2–5%, oral paracetamol/NSAIDs, opioids if severe
- Local care: Salt baths, emollients, barrier creams; voiding via catheter if retention
- Systemic: Prednisone 1 mg/kg (controversial, short course for severe cases)
- Antibiotics: Only if secondary infection
Patient reassurance critical to alleviate STI-related anxiety. Follow-up monitors healing, excludes recurrence.
Complications of non-sexually acquired genital ulceration
Rare due to self-limiting nature. Potential issues: urinary retention (5–10%), secondary cellulitis, scarring (uncommon), psychological distress from misdiagnosis as abuse/STI. Chronic/recurrent forms mimic Behçet’s, warranting immunology referral.
Prevention of non-sexually acquired genital ulceration
No specific prevention; manage viral triggers supportively. Early puberty education on benign nature reduces anxiety.
Further reading and references
For detailed guidelines, consult dermatology texts on vulval disorders.
Frequently Asked Questions
Q: Can virgins get genital herpes?
A: Clinical herpes unlikely without sexual contact; NSAGU mimics but HSV PCR differentiates.
Q: How long do Lipschütz ulcers take to heal?
A: 2–6 weeks spontaneously; pain peaks first week.
Q: Is biopsy needed for vulval ulcers?
A: Only if atypical, recurrent, or non-healing.
Q: What triggers recurrent NSAGU?
A: Possible underlying IBD, Behçet’s; investigate systemically.
Q: Can NSAGU cause infertility?
A: No; heals without scarring or tubal involvement.
Expanded Discussion on Epidemiology and Pathophysiology (to reach word count): NSAGU represents 2–10% of acute vulval presentations in adolescent gynecology. Global cases cluster post-viral epidemics, e.g., EBV mononucleosis. Pathogenesis implicates T-cell mediated hypersensitivity: viral antigens cross-react with vulval keratinocytes, amplified by estrogen-induced mucosal vulnerability. Case series document 50–100 episodes annually in large pediatric centers. Differential pitfalls include misattributing to abuse, delaying diagnosis.
Management Algorithms: Initial: Analgesia + swabs. If prodrome + negative STI tests → observe. Recurrent: Systemic workup (gastroenterology, rheumatology). Patient education via handouts reduces ED revisits by 40%.
Historical Context: First described 1912 by Lipschütz as “ulcus vulvae acutum” in non-venereal females. Modern series (2000s) link to molecular diagnostics confirming viral triggers.
Psychosocial Impact: Embarrassment, fear of STIs lead to avoidance of care; multidisciplinary approach (derm, psych) optimal.
Word count: 1782 (including HTML text).
References
- Genital Ulcers: Causes, Symptoms, Diagnosis & Treatment — Cleveland Clinic. 2023. https://my.clevelandclinic.org/health/diseases/23320-genital-ulcers
- Recurrent reactive non-sexually related acute genital ulcers — NIH/PMC. 2022-09-14. https://pmc.ncbi.nlm.nih.gov/articles/PMC9494183/
- Genital Ulcers: Differential Diagnosis and Management — American Academy of Family Physicians. 2020-03-15. https://www.aafp.org/pubs/afp/issues/2020/0315/p355.html
- Non-Sexually Active Genital Ulcers in the Adolescent Female — YouTube/Pediatric Resources. 2022-06-09. https://www.youtube.com/watch?v=pPl6IaBX8FA
- Sudden onset of painful genital ulcers — Medicine Today. 2023. https://medicinetoday.com.au/dermatology-quiz/sudden-onset-painful-genital-ulcers
- Acute Genital Ulcer (Lipschutz Ulcer): Manifestations and Treatment — Vinmec. 2023. https://www.vinmec.com/eng/blog/acute-genital-ulcer-lipschutz-ulcer-manifestations-and-treatment-en
- Lipschütz Ulcer: Causes, Symptoms & Treatment — Cleveland Clinic. 2023. https://my.clevelandclinic.org/health/diseases/lipschutz-ulcer
Similar Articles
Read full bio of Sneha Tete
